FoodMarble is an interesting Irish startup that has just raised a further €2.14m in seed funding.
FoodMarble is a personal hydrogen breath test device that connects to an app and allows people to diagnose any digestive issues they may have.
Digestive issues are a common and often untreated issue for people all around the globe, affecting up to one in eight people. Roughly one billion people have IBS, and many more have food intolerances to everyday food items such as lactose, wheat, and fructose.
“Healthcare systems today are not suited to helping people with certain common but incredibly challenging gut health issues,” suggests Aonghus Shortt, co-founder and CEO at FoodMarble.
“Digestive symptoms can be deeply disruptive to normal life, and we’re seeking to end that. Our mission is to help people cut through the complexity and uncertainty to find ‘their foods’.
“We started as a direct-to-consumer business, and we’re happy to now be able to also assist clinicians in managing their patient’s digestive health. We’re just getting started. We want this to be a tool that every family can have in the home to monitor and manage their digestive health so that they can live healthy and happy lives.”
Several clinicians and hospitals have started using the FoodMarble product. The startup also has an ongoing clinical trial with Johns Hopkins. The devices will be sold in a number of BigBox stores in the US in 2021. So far, the business has sold 20,000 devices direct to consumer.
In addition to the money raised in the seed investment round, FoodMarble has opted to raise further funding through an equity crowdfunding campaign on Seedrs. Due to high demand and interest in the company, FoodMarble opened its funding to the public. The crowdfunding campaign is live here: seedrs.com/foodmarble.
Pictured are co-founders Aonghus Shortt, CEO (centre); Lisa Rutledge COO, and Peter Harte CTO.